Further, our studies showed that TG02 killed the CLL cells efficiently in the presence of stroma protection or BCR crosslinking (Figs.4A, 5A), demonstrating that BCR activation or stroma does not provide substantial protection from apoptosis induced by Mcl-1 depletion. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.